SPK transplant has no survival benefits for type 2 diabetes patients

04/18/2012 | Renal and Urology News

Data on 6,416 type 2 diabetes patients revealed those who underwent simultaneous pancreas-kidney transplantation had an 82% five-year survival rate compared with 75.5% in those who had deceased-donor kidney transplantation alone. However, researchers said the difference was related to younger donor and recipients ages in the SPK group. The study also found that the five-year death-censored graft survival was 86.2% in SPK recipients and 82.6% in those who had DDKA, a non-significant difference. The findings appear in the Clinical Journal of the American Society of Nephrology.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ